Avalon Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Avalon Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,796	Closed	-$602K	–	25
2020 Q1	$602K	Sell	10,796 -1,049	-9%	-$64.1K	0.71%	18
2019 Q4	$760K	Buy	+11,845	New	+$678K	0.92%	24
2017 Q4	–	Sell	-33,907	Closed	-$2.16M	–	75
2017 Q3	$2.16M	Buy	+33,907	New	+$1.98M	1.5%	21
2016 Q1	–	Sell	-18,076	Closed	-$1.24M	–	73
2015 Q4	$1.24M	Buy	+18,076	New	+$1.19M	1.12%	37
2015 Q3	–	Sell	-37,740	Closed	-$2.51M	–	60
2015 Q2	$2.51M	Buy	+37,740	New	+$2.49M	2.29%	17
2013 Q4	–	Sell	-38,566	Closed	-$1.78M	–	102
2013 Q3	$1.78M	Buy	+38,566	New	+$1.69M	1.76%	14

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Avalon Capital Management's BMY Position: Q2 2020 in Review

Avalon Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 10,796 shares — an estimated $602K sold.

Avalon Capital Management first reported a position in BMY in Q3 2013 and held it in 6 quarters. The position peaked at $2.51M in Q2 2015. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

Avalon Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
Avalon Capital Management sold 10,796 Bristol-Myers Squibb shares in Q2 2020, an estimated $602K.
Avalon Capital Management first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 6 quarters.
Avalon Capital Management's Bristol-Myers Squibb position peaked at $2.51M in Q2 2015.
2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Avalon Capital Management's 13F filing for Q2 2020, filed 14 Jul 2020.